Resources

Ten Mistakes to Avoid when Searching Gene Sequences

Avoid the costly pitfalls of inaccurate, irrelevant, and untimely search results - what you need to consider before your next search.
Learn More»

The value of a cost-effective informatics platform that enables rapid and relevant search of the vast universe of sequences and their patents with regard to commercialization of new drugs cannot be understated. This is particularly true in the fast-paced R&D area of infectious disease research. We selected GenomeQuest™ for its ability to instantly locate sequence data and display it in an intuitive and easily manipulated format..
More About Our Customers »

Research Decision-Making

Research directors strive to focus their efforts on their most viable opportunities. That means they don't like to waste their valuable time and resources on scientific dead ends or big projects that come to rest in a confusing tangle of IP issues.

Direct access to GenomeQuest's patent sequence record is essential. A greater-than-tenfold disparity exists between the number of sequences in the GenBank Patent Division and GenomeQuest's GQ-PAT patent sequence database, and it's unlikely that GenBank will catch up soon. In addition, certain key categories of information, such as new gene expression data and new chemical inhibitors of gene activity, typically appear first in patents.

GenomeQuest helps research directors steer clear of disappointing project outcomes by providing the tools and information they need to survey the IP landscape prior to pursuing any specific avenue of research. Other projects with preferable IP profiles or design-around strategies can be profitably pursued when IP analysis is used to inform research decision-making. Early awareness of relevant IP positions can save millions, or billions, of dollars of R&D funding by enabling research directors to avoid projects that would eventually fail due to IP constraints.